Quality of Life of Brazilian Patients with Gaucher Disease and Fabry Disease
- 18 April 2012
- book chapter
- Published by Springer Science and Business Media LLC
- Vol. 7, 31-37
- https://doi.org/10.1007/8904_2012_136
Abstract
Objective: To evaluate QoL in a sample of Brazilian patients with Gaucher (GD) and Fabry (FD) disease using the SF-36 survey. Method: Observational cross-sectional study. The SF-36 survey was administered to cognitively able patients 12 years or older, who were seen in the Medical Genetics Service of Hospital de Clínicas de Porto Alegre, Brazil. Results: Thirty-five patients were included in the study (GD = 21, FD = 14), mean age was 29.8 ± 14.2 years and 29 (82.9%) were receiving ERT. Patients with GD receiving ERT had better scores in the general health (p = 0.046) domain of the SF-36 than patients with FD receiving ERT. Comparison of patients with GD naive to ERT and those receiving ERT revealed differences only in the bodily pain domain (p = 0.036). The Zimran score showed a moderate negative correlation with the following domains of the SF-36: physical functioning (p = 0.035), role-physical (p = 0.036), general health (p = 0.023) and role emotional (p = 0.021). Discussion and Conclusion: Although limited because of the small number of patients included, findings suggest that patients with GD receiving ERT have a better QoL than patients with FD or with GD not receiving ERT. Imiglucerase has a beneficial effect against pain for patients with GD. Further studies should be conducted to confirm our findings.Keywords
This publication has 22 references indexed in Scilit:
- Expression of the disease on female carriers of X-linked lysosomal disorders: a brief reviewOrphanet Journal of Rare Diseases, 2010
- Imiglucerase (Cerezyme®) improves quality of life in patients with skeletal manifestations of Gaucher diseaseClinical Genetics, 2007
- Glycosphingolipidoses: Beyond the enzymatic defectGlycoconjugate Journal, 2004
- Lysosomal disordersSeminars in Neonatology, 2002
- The frequency of lysosomal storage diseases in The NetherlandsHuman Genetics, 1999
- The health-related quality of life of adults with Gaucher‘s disease receiving enzyme replacement therapy: results from a retrospective studyQuality of Life Research, 1998
- Lysosomal storage diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- Gaucher DiseaseMedicine, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992